Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

Nike Faces Critical Test as Quarterly Results Loom

Dieter Jaworski by Dieter Jaworski
September 28, 2025
in Stocks
0
Nike Stock
0
SHARES
96
VIEWS
Share on FacebookShare on Twitter

All eyes are on sportswear titan Nike this week, with the company scheduled to release its first-quarter financial results after markets close on Tuesday. The announcement arrives amidst a stark divergence in market sentiment: while consensus earnings forecasts appear bleak, several major Wall Street institutions are striking an unexpectedly optimistic tone. The pivotal question remains whether Nike can defy expectations or if it is headed for another disappointing performance.

Wall Street’s Surprising Confidence

Contrary to the prevailing gloomy outlook, a number of prominent investment banks are expressing bullishness on Nike’s prospects. Goldman Sachs has reaffirmed its “Buy” recommendation, maintaining a price target of $85. Showing even greater confidence, RBC Capital Markets upgraded the stock to “Outperform,” projecting a potential rise to $90 per share, a forecast largely based on anticipated improvements within the running shoe division.

This positive sentiment is echoed by other financial houses. UBS has increased its price objective to $71, while Telsey Advisory Group raised its target to $75. Jefferies remains the most ambitious, standing by a “Buy” rating and a price target of $115.

High Stakes and Harsh Realities

The optimism from analysts stands in sharp contrast to the concrete financial projections for the quarter. Market experts anticipate earnings per share to land between just $0.27 and $0.28, which would represent a dramatic year-over-year decline of 61.5 percent. Revenue is expected to come in at approximately $11 billion.

Should investors sell immediately? Or is it worth buying Nike?

Investors will be scrutinizing three critical areas for signs of the company’s future trajectory:
* Performance in the crucial Chinese market
* Progress in reducing excess inventory levels
* The margin impact of recent U.S. tariff policies

The last point carries significant weight; Nike has estimated that tariff policies could impose additional costs of up to $1.5 billion by fiscal year 2026.

Strategic Moves and Market Pressure

In a strategic move just days before the earnings release, Nike announced a new collaboration with the shapewear brand SKIMS, launching an activewear line on September 26. Market researchers view this partnership as a potentially innovative step, though its ability to offset fundamental operational challenges is uncertain.

Nike’s shares continue to struggle, heading for a potential fifth consecutive weekly loss. Since a price surge in June, the stock has been trading in a narrow range between $70 and $80, reflecting persistent market uncertainty. This pressure was compounded by a recent sale of 110,000 shares by Executive Chairman Mark G. Parker.

Ad

Nike Stock: Buy or Sell?! New Nike Analysis from March 25 delivers the answer:

The latest Nike figures speak for themselves: Urgent action needed for Nike investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Nike: Buy or sell? Read more here...

Tags: Nike
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Eli Lilly Stock
Stocks

Eli Lilly’s Strategic Diversification Amid Weight-Loss Drug Competition

November 18, 2025
Micron Stock
Stocks

Micron Shares Approach Peak: What Comes After the AI Rally?

November 18, 2025
Varonis Stock
Stocks

Varonis Shares Plunge Amidst Mixed Signals

November 18, 2025
Next Post
Realty Income Stock

Realty Income Secures Major Funding for Strategic Growth Push

Synopsys Stock

Synopsys Shares Plunge Following Disappointing Quarterly Results

UPS Stock

Is UPS's Dividend Payout Sustainable Amid Mounting Pressure?

Recommended

Banner Stock

All Eyes on Fed as Banner Corporation Awaits Rate Decision

6 months ago
Dynatrace Holdings LLC Stock

Dynatrace Holdings LLC Stock: Strong Q1 Performance Beats Expectations

8 months ago
MP Materials Stock

MP Materials: Record Production Amid Financial Headwinds

4 months ago
Omv Stock

OMV Faces Critical Juncture as Qatar Threatens European Gas Supplies

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Evolent Health Bets on AI Leadership Amid Share Price Decline

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Hain Celestial Sheds Snack Division in Strategic Overhaul

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Trending

Fair Isaac Stock
Analysis

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

by Jackson Burston
March 25, 2026
0

Fair Isaac Corporation, the company behind the ubiquitous FICO credit score, is facing a dual-pronged assault that...

Figma Stock

Figma Embraces Third-Party AI to Power Its Design Ecosystem

March 25, 2026
BioNano Genomics Stock

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026
Humacyte Stock

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026
Evolent Health Stock

Evolent Health Bets on AI Leadership Amid Share Price Decline

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance
  • Figma Embraces Third-Party AI to Power Its Design Ecosystem
  • BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com